BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
3.940
+0.120 (3.14%)
At close: May 16, 2025, 4:00 PM
3.940
0.00 (0.00%)
After-hours: May 16, 2025, 4:05 PM EDT
BioAge Labs Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for BioAge Labs stock ranges from a low of $5.00 to a high of $7.00. The average analyst price target of $5.67 forecasts a 43.91% increase in the stock price over the next year.
Price Target: $5.67 (+43.91%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 24, 2025.
Analyst Ratings
The average analyst rating for BioAge Labs stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +26.90% | Mar 24, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Initiates $5 | Sell | Initiates | $5 | +26.90% | Mar 7, 2025 |
| William Blair | William Blair | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 28, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $45 → $7 | Strong Buy → Hold | Downgrades | $45 → $7 | +77.66% | Dec 9, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $42 → $7 | Strong Buy → Hold | Downgrades | $42 → $7 | +77.66% | Dec 9, 2024 |
Financial Forecast
Revenue This Year
n/a
from 1.70M
Revenue Next Year
n/a
EPS This Year
-2.18
from -6.63
EPS Next Year
-2.42
from -2.18
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 7.0M | 7.0M | 7.0M |
| Avg | 2.5M | 1.7M | 1.7M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 311.8% | 185.9% | 311.3% |
| Avg | 44.2% | -30.6% | -0.1% |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.59 | -1.24 | -1.48 |
| Avg | -2.18 | -2.42 | -2.61 |
| Low | -2.89 | -3.03 | -3.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.